Cargando…
Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic
BACKGROUND: In December 2019, a novel coronavirus, SARS-CoV-2 caused a series of acute atypical respiratory diseases worldwide. However, there is still a lack of drugs with clear curative effects, and the clinical trial research of vaccines has not been completely finished. PURPOSE: LH capsules are...
Autores principales: | Liang, Chengyuan, Hui, Nan, Liu, Yuzhi, Qiao, Guaiping, Li, Juan, Tian, Lei, Ju, Xingke, Jia, Minyi, Liu, Hong, Cao, Wenqiang, Yu, Pengcheng, Li, Han, Ren, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833308/ https://www.ncbi.nlm.nih.gov/pubmed/35399819 http://dx.doi.org/10.1016/j.phyplu.2021.100027 |
Ejemplares similares
-
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
por: Hu, Ke, et al.
Publicado: (2021) -
Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021) -
Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Dong, Liang, et al.
Publicado: (2014) -
Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis
por: Liu, Ming, et al.
Publicado: (2021) -
Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
por: Gong, Xiaowei, et al.
Publicado: (2021)